{"slideshow_credits": null, "snippet": "AstraZeneca\u2019s board would do well to evaluate whether the company\u2019s progress will continue under Pfizer\u2019s management, Bill George, a professor at Harvard Business School, writes in the Another View column.", "abstract": "AstraZeneca\u2019s board would do well to evaluate whether the company\u2019s progress will continue under Pfizer\u2019s management, Bill George, a professor at Harvard Business School, writes in the Another View column.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Bill", "role": "reported", "lastname": "GEORGE", "rank": 1, "organization": ""}], "original": "By BILL GEORGE"}, "web_url": "http://dealbook.nytimes.com/2014/05/08/a-case-for-rejecting-pfizers-bid-for-astrazeneca/", "lead_paragraph": null, "headline": {"main": "A Case for Rejecting Pfizer's Bid for AstraZeneca", "kicker": "DealBook"}, "_id": "536bdcd238f0d874ed900ce6", "word_count": "906", "multimedia": [{"height": 126, "url": "images/2014/05/09/business/dbpix-soriot/dbpix-soriot-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/05/09/business/dbpix-soriot/dbpix-soriot-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2014/05/09/business/dbpix-pfizer1/dbpix-pfizer1-articleLarge.jpg", "legacy": {"xlarge": "images/2014/05/09/business/dbpix-pfizer1/dbpix-pfizer1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/05/09/business/dbpix-soriot/dbpix-soriot-thumbStandard-v2.jpg", "legacy": {"thumbnail": "images/2014/05/09/business/dbpix-soriot/dbpix-soriot-thumbStandard-v2.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-05-08T15:35:49Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "persons", "value": "Read, Ian C", "rank": "1"}, {"name": "persons", "value": "Soriot, Pascal", "rank": "2"}, {"name": "organizations", "value": "Pfizer Inc", "rank": "2"}, {"name": "organizations", "value": "AstraZeneca PLC", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}